CN112089776A - 一种治疗赤游丹风火热毒证的中药软膏 - Google Patents
一种治疗赤游丹风火热毒证的中药软膏 Download PDFInfo
- Publication number
- CN112089776A CN112089776A CN201910557787.4A CN201910557787A CN112089776A CN 112089776 A CN112089776 A CN 112089776A CN 201910557787 A CN201910557787 A CN 201910557787A CN 112089776 A CN112089776 A CN 112089776A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- chinese medicine
- percent
- liquid medicine
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 120
- 208000011580 syndromic disease Diseases 0.000 title claims abstract description 29
- 239000003053 toxin Substances 0.000 title claims abstract description 28
- 239000002674 ointment Substances 0.000 title claims abstract description 24
- 239000008188 pellet Substances 0.000 title claims description 7
- 244000207740 Lemna minor Species 0.000 claims abstract description 29
- 235000006439 Lemna minor Nutrition 0.000 claims abstract description 29
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 29
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 29
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 27
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 27
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 26
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 26
- 235000020224 almond Nutrition 0.000 claims abstract description 26
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 26
- 235000011477 liquorice Nutrition 0.000 claims abstract description 26
- 241000735527 Eupatorium Species 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 241000628997 Flos Species 0.000 claims abstract description 19
- 201000000297 Erysipelas Diseases 0.000 claims abstract description 13
- 210000003056 antler Anatomy 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims description 50
- 240000003582 Platycodon grandiflorus Species 0.000 claims description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
- 239000000341 volatile oil Substances 0.000 claims description 23
- 238000010438 heat treatment Methods 0.000 claims description 19
- 238000000605 extraction Methods 0.000 claims description 17
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 15
- 238000009835 boiling Methods 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 8
- 229960004926 chlorobutanol Drugs 0.000 claims description 8
- 239000003651 drinking water Substances 0.000 claims description 8
- 235000020188 drinking water Nutrition 0.000 claims description 8
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 8
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 claims description 6
- 241001164374 Calyx Species 0.000 claims description 6
- 229920002101 Chitin Polymers 0.000 claims description 6
- 241001071917 Lithospermum Species 0.000 claims description 6
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 18
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 19
- 206010038743 Restlessness Diseases 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 231100000765 toxin Toxicity 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 230000001717 pathogenic effect Effects 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000000440 neutrophil Anatomy 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 206010063659 Aversion Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 208000021760 high fever Diseases 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010060891 General symptom Diseases 0.000 description 2
- 235000019687 Lamb Nutrition 0.000 description 2
- 240000000599 Lentinula edodes Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000308663 Eupatorium fortunei Species 0.000 description 1
- 206010018833 Haematocoele Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000005873 Hematocele Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000020241 Neonatal disease Diseases 0.000 description 1
- 208000037129 Newborn Diseases Infant Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010040893 Skin necrosis Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 201000004920 hematocele of tunica vaginalis testis Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/02—Recovery or refining of essential oils from raw materials
- C11B9/025—Recovery by solvent extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗赤游丹风火热毒证的中药软膏,涉及中医药领域,其特征在于:它由下列质量百分比的中药原料制成:浮萍11.11‑16.67%、桔梗11.11‑16.67%、佩兰13.34‑20.00%、杏仁11.11‑16.67%、绿萼梅10.00‑15.00%、紫草茸16.65‑25.00%、甘草6.65‑10.00%;其中各中药原料组分含量百分数之和等于100%;该中药软膏使用方便,对症性强,治疗效果好,治愈率98.11%,有效率100%。
Description
技术领域
本发明涉及中医药领域,尤其涉及一种治疗赤游丹风火热毒证的中药软膏。
背景技术
赤游丹,又名赤游风。是指以发病部位出现皮肤红肿,形如云片、色赤如丹、游走不定为主要表现的新生儿疾病。此病发病急骤,初起局部皮肤鲜红或片状,形似云彩,漫延迅速,灼热疼痛,稍高出皮肤,边缘清楚,游走不定,可伴恶寒高热等全身症状,患部可伴发水疱,偶有结毒化脓,皮肤溃烂,坏死,而致蛀骨。治疗不当可因邪毒入侵内脏,致高热、神昏、抽搐甚至死亡。现代中医学认为:赤游丹的发病原因,多由局部皮肤损伤、脐部疾患、臀部湿疹、虫咬、护理不善等,为歪风邪毒所侵,以致感染成病,邪毒入经脉,随气血流走全身,发于肌表,因而出现红肿、灼热、疼痛等风火热毒证候。目前,中医的治则是疏风散邪、泻火解毒、或凉血解毒、开窍熄风。但申请人认为,中医对该病的认识及治疗方法还有待完善,本人经多年研究及临床实践表明:因新生儿为稚阴稚阳之体,肺为娇脏,宣发肃降功能低下,随之皮肤的防御功能也低下,所以风热邪毒,易侵袭新生儿体表,入肺经;当风热邪毒侵袭患儿体表,易致体表气滞,营卫不调,气滞则湿郁,湿郁则化火,导致发热、恶寒;气滞致血瘀,发病部位皮肤可见红肿;再因手太阴肺经与手厥阴心包经相连,风热由肺经逆传至心包经,导致高热不退,神志昏迷。治疗宜轻宣肺脏透邪,健脾行气化滞祛瘀。
发明内容
本发明在于克服现有技术的不足,提供一种对症性强,显效快,治疗效果好,治愈率高,且治疗方便的一种治疗赤游丹风火热毒证的中药软膏。
为了达到以上目的,本发明所采取的技术方案是,该一种治疗赤游丹风火热毒证的中药软膏,其特征在于:它由下列质量百分比的中药原料制成:浮萍11.11-16.67%、桔梗11.11-16.67%、佩兰13.34-20.00%、杏仁11.11-16.67%、绿萼梅10.00-15.00%、紫草茸16.65-25.00%、甘草6.65-10.00%;其中各中药原料组分含量百分数之和等于100%。优化中药原料组方为:浮萍13.89%、桔梗13.89%、佩兰16.67%、杏仁13.89%、绿萼梅12.5%、紫草茸20.83%、甘草8.33%。一种治疗赤游丹风火热毒证的中药软膏由以下步骤制作:一、按浮萍11.11-16.67%、桔梗(挥发油)11.11-16.67%、绿萼梅(挥发油)10.00-15.00%、杏仁(挥发油)11.11-16.67%、佩兰(挥发油)13.34-20.00%、紫草茸16.65-25.00%、甘草(挥发油)6.65-10.00%的比例准确称取炮制好的各中药原料,在称取各中药原料时,将桔梗、绿萼梅、杏仁、佩兰、甘草混放在一起,将浮萍、紫草茸混放在一起;二、将混放在一起的桔梗、绿萼梅、杏仁、佩兰、甘草放入多功能提取罐,并向多能提取罐中加生活饮用水,搅拌,加水量为称好的中药原料桔梗、绿萼梅、杏仁、佩兰、甘草质量之和的6-8倍,浸泡30分钟,加热常压提取挥发油,提取时间为100分钟,提取完毕,取下挥发油冷藏备用;三、在提取挥发油进行70分钟时将混放在一起的浮萍、紫草茸放入煮药锅,并向煮药锅内加生活饮用水,加水量为浮萍、紫草茸质量之和的7-8倍,搅拌均匀,浸泡10分钟,武火加热至沸,改文火煎煮30分钟,停止加热,过滤,留渣,得一次药液;四、将提取罐中的药液混合物过滤,留渣,得过滤药液;五、将提取罐中的药渣并入煮药锅,加生活饮用水,加水量为浮萍、桔梗、绿萼梅、杏仁、佩兰、紫草茸、甘草质量之和的4-5倍,武火加热至沸,改文火煎煮30分钟,停止加热,过滤,留渣,得二次药液;六、将一次药液、二次药液,过滤药液都放入不锈钢筒混合得混合药液;向混合药液中加甲壳素,搅匀,甲壳素的添加量为混合药液质量的3/万,45℃保温12小时,取上清液;七、将上清液放入离心机,离心处理10分钟,转鼓转数9000-10000转/分钟,弃渣,得净化药液;八、将净化药液倒入煮药锅,加热浓缩,浓缩至每毫升药液中含1.5-2克中药原料的提取物时,停止加热,得浓缩药液;九、向浓缩药液中加入羧甲基纤维素钠、甘油、三氯叔丁醇;添加的量:每1000毫升浓缩药液加羧甲基纤维素钠60克,甘油150克,三氯叔丁醇5克;添加的方法:将羧甲基纤维素钠和甘油研匀,加入热浓缩药液,搅拌,降到自然温度时再加入三氯叔丁醇和备用的中药挥发油,搅拌均匀,装瓶,封盖,每瓶50毫升;即为一种治疗赤游丹风火热毒证的中药软膏。
组方中,君药浮萍、臣药桔梗、佐药佩兰、使药甘草;浮萍宣表疏风透邪,桔梗宣发肺气,佩兰化湿健脾,甘草健脾胃缓药性;紫草茸凉血解毒,破瘀行气止痛,助力浮萍;杏仁肃降肺气助力桔梗;绿萼梅理气化湿健脾助力佩兰。
该一种治疗赤游丹风火热毒证的中药软膏其组方药理为:宣肺降气、疏风解表透邪,凉血解毒,健脾化湿,行气化滞祛瘀。
其中:浮萍——味辛,性寒;归肺、膀胱经。具有发汗解表,止痒,透疹,利水消肿之功效。用于外感表证,发热无汗,较宜用于风热表证无汗者。浮萍为发散风热药,发散风热药性偏寒凉,味辛而多苦。辛散以祛风,苦寒则清热。
桔梗——味苦、辛,性微寒;归肺经。具有祛痰止咳,利咽,解毒排脓之功效。桔梗苦,长于降肺气;辛开宣肺气,以畅利胸中气机;性微寒而不盛,故应用广泛。
佩兰——味辛,性平;归脾、胃、肺经。具有化湿、解表之功效。本品气味芳香,其化湿醒脾作用与广藿香相似而力缓。又因本品药性平和,不偏温燥,故尤长于治疗脾经湿热阻中证。
杏仁——味苦,性温,有小毒;归肺大肠经。具有止咳平喘、润肠通便之功效。杏仁苦能降肺气,又略兼宣肺之功。
绿萼梅——味辛、涩,性平;归肝、胃、肺经。具有疏肝和胃、理气化痰之功效。本品芳香行气,既能疏肝解郁,又能理气和胃。且性平,寒热病症皆可用。
紫草茸——味苦,性平;归肺、肝经。具有清热,凉血,解毒,破瘀行气止痛之功效。《唐本草》:“主五脏邪气,带下,心痛,破积血,金疮生肉。”紫草茸既能解毒活血,又无作泻之患。
甘草——味甘,性微寒,归心、肺、脾、胃经。具有补心脾气,止咳、去痰、平喘,缓急止痛,清热解毒,调和药性之功效。本品长于补益心气,本品在许多方剂中都发挥调和药性的作用,通过解毒,可降低某些药中的毒性。
该一种治疗赤游丹风火热毒证的中药软膏的使用方法为:涂抹患处,涂抹面积大出红肿处1-2厘米,一日3次,7天为一个疗程。
服药禁忌:母乳喂养患儿的母亲在患儿用药期间忌食辛辣,膻腥甘厚之品。
本发明的有益效果在于:该一种治疗赤游丹风火热毒证的中药软膏使用方便,对症性强,治疗效果好,治愈率98.11%,有效率100%。
临床资料分析
一、诊断依据
依据中华人民共和国中医药行业标准-中医病证诊断疗效标准(ZY-T001.1-94)中医外科丹毒的诊断标准制定:
1、多发于新生儿。
2、局部皮肤红肿,形如云片,焮热疼痛,游走不定。
3、发热恶寒,烦躁多啼;舌红,苔黄或白;脉数。
4、血白细胞总数及中性粒细胞明显增高。
二、疗效评定
依据中华人民共和国中医药行业标准-中医病证诊断疗效标准(ZY-T001.1-94)中医外科丹毒的疗效标准制定。
1、治愈:全身及局部症状消退,血象正常。
2、好转:全身症状消退,局部症状未全消。
3、未愈:全身与局部症状未能控制。
三、疗效结果分析
自2010年1月至2018年12月,共确诊赤游丹风火热毒证患儿53例,其中,男性患儿28例,女性患儿25例,年龄最小的出生18天,最大的6个月,用该软膏外敷治疗1-2个疗程,治愈52例,治愈率为98.11%;好转1例,好转率1.89%;有效率100%。
具体实施例
实施例一
按浮萍13.89%、桔梗13.89%、佩兰16.67%、杏仁13.89%、绿萼梅12.5%、紫草茸20.83%、甘草8.33%的比例准确称取炮制好的中药原料共1000克,其中浮萍138.9克、桔梗138.9克、佩兰166.7克、杏仁138.9克、绿萼梅125克、紫草茸208.3克、甘草83.3克。
在称取各中药原料时,将桔梗、绿萼梅、杏仁、佩兰、甘草混放在一起,将浮萍、紫草茸混放在一起;将混放在一起的桔梗、绿萼梅、杏仁、佩兰、甘草放入多功能提取罐,并向多能提取罐中加生活饮用水,搅拌,加水量为称好的中药原料桔梗、绿萼梅、杏仁、佩兰、甘草质量之和的6-8倍,浸泡30分钟,加热常压提取挥发油,提取时间为100分钟,提取完毕,取下挥发油冷藏备用;在提取挥发油进行70分钟时将混放在一起的浮萍、紫草茸放入煮药锅,并向煮药锅内加生活饮用水,加水量为浮萍、紫草茸质量之和的7-8倍,搅拌均匀,浸泡10分钟,武火加热至沸,改文火煎煮30分钟,停止加热,过滤,留渣,得一次药液;四、将提取罐中的药液混合物过滤,留渣,得过滤药液;将提取罐中的药渣并入煮药锅,加生活用水,加水量为浮萍、桔梗、绿萼梅、杏仁、佩兰、紫草茸、甘草质量之和的4-5倍,武火加热至沸,改文火煎煮30分钟,停止加热,过滤,留渣,得二次药液;将一次药液、二次药液,过滤药液都放入不锈钢筒混合得混合药液;向混合药液中加甲壳素,搅匀,甲壳素的添加量为混合药液质量的3/万,45℃保温12小时,取上清液;将上清液放入离心机,离心处理10分钟,转鼓转数9000-10000转/分钟,弃渣,得净化药液;将净化药液倒入煮药锅,加热浓缩,浓缩至每毫升药液中含1.6克中药原料的提取物时,停止加热,得浓缩药液625毫升;准确称取羧甲基纤维素钠37.5克,甘油93.75克、三氯叔丁醇3.13克;将称好的羧甲基纤维素钠和甘油研匀,加入热浓缩药液,搅拌,降到自然温度时再加入称好的三氯叔丁醇和备用的中药挥发油,搅拌均匀,装瓶,封盖,每瓶50毫升;即为一种治疗赤游丹风火热毒证的中药软膏。
用该软膏治疗赤游丹风火热毒证患儿21例,治愈21例,治愈率100%。
典型病例
李某,女,出生23天,莱芜区苗山镇人,2011年4月27日由家长带到我处就诊。家长述:自昨日下午患儿多烦躁啼哭,夜间发热,无流涕、咳嗽症状,今早发现腹部小片红斑,形如片云,游走不定,经医务室介绍前来就诊。诊见:局部红肿,略高出正常皮肤,压之褪色,舌红,苔薄黄,脉数;患儿体温37.6℃,血常规检验白细胞18×109/L,中性粒细胞百分比为85;诊断为新生儿赤游丹,让其涂抹该一种治疗赤游丹风火热毒证的中药软膏,每日三次,治疗5天好转,一个疗程全身及局部症状消失,血象正常。随访半年,无复发。
实施例2
按浮萍12.50%、桔梗14.50%、佩兰17.00%、杏仁13.50%、绿萼梅12.50%、紫草茸22.50%、甘草7.50%的比例准确称取炮制好的中药原料共1000克,其中浮萍125克、桔梗145克、佩兰170克、杏仁135克、绿萼梅125克、紫草茸225克、甘草75克。
制作方法同实施例1。
用该软膏治疗赤游丹风火热毒证患儿17例,治愈16例,治愈率94.12%;好转1例,好转率5.88%,有效率100%。
典型病例
刘某,男,出生25天,莱芜区茶业口镇人,2015年10月12日由家长带到我处就诊,家长述:患儿自今天凌晨焦躁啼哭不停,发热,继而面部出现稍微突出皮肤表面的红斑,形如片云,无其他感冒症状,也不知孩子得的什么病,所以前来就诊。诊见:红斑炘红灼热,舌红,苔白,脉洪数;患儿体温38.1℃,血常规检验白细胞18.6×109/L,中性粒细胞百分比为86.7;诊断为新生儿赤游丹,让其涂抹该一种治疗赤游丹风火热毒证的中药软膏,每日三次,用药一个疗程,病情大有好转,又用一个疗程,全身及局部症状消失,血象正常。随访半年,无复发。
实施例3
按浮萍15.50%、桔梗12.50%、佩兰15.00%、杏仁15.50%、绿萼梅13.50%、紫草茸19.50%、甘草8.50%的比例准确称取炮制好的中药原料共1000克,其中浮萍155克、桔梗125克、佩兰150克、杏仁155克、绿萼梅135克、紫草茸195克、甘草85克。
制作方法同实施例1。
用该软膏治疗赤游丹风火热毒证患儿15例,治愈15例,治愈率100%。
典型病例
张某,男,2个月11天。莱芜区羊里镇人,2018年8月5日由家长带到我处就诊。家长述:患儿自昨日下午发热,烦躁啼哭不停,右下肢皮肤红肿,形如云片,高出皮肤,游走不定,无流涕、咳嗽症状,到镇医院去,医生说不像感冒,介绍到我处就诊。诊见:红斑焮热,舌红,苔黄,脉数;患儿体温37.8℃,血常规检验白细胞18.3×109/L,中性粒细胞百分比为85.5;诊断为新生儿赤游丹,让其涂抹该一种治疗赤游丹风火热毒证的中药软膏,每日三次,用药一个疗程,全身症状消退,局部症状末全消,又用一个疗程,全身及局部症状消失,血象正常。随访半年,无复发。
Claims (3)
1.一种治疗赤游丹风火热毒证的中药软膏,其特征在于:它由下列质量百分比的中药原料制成:浮萍11.11-16.67%、桔梗11.11-16.67%、佩兰13.34-20.00%、杏仁11.11-16.67%、绿萼梅10.00-15.00%、紫草茸16.65-25.00%、甘草6.65-10.00%;其中各中药原料组分含量百分数之和等于100%。
2.根据权利要求1所述的一种治疗赤游丹风火热毒证的中药软膏,其特征在于:优化中药原料组方为:浮萍13.89%、桔梗13.89%、佩兰16.67%、杏仁13.89%、绿萼梅12.5%、紫草茸20.83%、甘草8.33%。
3.根据权利要求1所述的一种治疗赤游丹风火热毒证的中药软膏,其特征在于:由以下步骤制作:一、按浮萍11.11-16.67%、桔梗(挥发油)11.11-16.67%、绿萼梅(挥发油)10.00-15.00%、杏仁(挥发油)11.11-16.67%、佩兰(挥发油)13.34-20.00%、紫草茸16.65-25.00%、甘草(挥发油)6.65-10.00%的比例准确称取炮制好的各中药原料,在称取各中药原料时,将桔梗、绿萼梅、杏仁、佩兰、甘草混放在一起,将浮萍、紫草茸混放在一起;二、将混放在一起的桔梗、绿萼梅、杏仁、佩兰、甘草放入多功能提取罐,并向多能提取罐中加生活饮用水,搅拌,加水量为称好的中药原料桔梗、绿萼梅、杏仁、佩兰、甘草质量之和的6-8倍,浸泡30分钟,加热常压提取挥发油,提取时间为100分钟,提取完毕,取下挥发油冷藏备用;三、在提取挥发油进行70分钟时将混放在一起的浮萍、紫草茸放入煮药锅,并向煮药锅内加生活饮用水,加水量为浮萍、紫草茸质量之和的7-8倍,搅拌均匀,浸泡10分钟,武火加热至沸,改文火煎煮30分钟,停止加热,过滤,留渣,得一次药液;四、将提取罐中的药液混合物过滤,留渣,得过滤药液;五、将提取罐中的药渣并入煮药锅,加生活饮用水,加水量为浮萍、桔梗、绿萼梅、杏仁、佩兰、紫草茸、甘草质量之和的4-5倍,武火加热至沸,改文火煎煮30分钟,停止加热,过滤,留渣,得二次药液;六、将一次药液、二次药液,过滤药液都放入不锈钢筒混合得混合药液;向混合药液中加甲壳素,搅匀,甲壳素的添加量为混合药液质量的3/万,45℃保温12小时,取上清液;七、将上清液放入离心机,离心处理10分钟,转鼓转数9000-10000转/分钟,弃渣,得净化药液;八、将净化药液倒入煮药锅,加热浓缩,浓缩至每毫升药液中含1.5-2克中药原料的提取物时,停止加热,得浓缩药液;九、向浓缩药液中加入羧甲基纤维素钠、甘油、三氯叔丁醇;添加的量:每1000毫升浓缩药液加羧甲基纤维素钠60克,甘油150克,三氯叔丁醇5克;添加的方法:将羧甲基纤维素钠和甘油研匀,加入热浓缩药液,搅拌,降到自然温度时再加入三氯叔丁醇和备用的中药挥发油,搅拌均匀,装瓶,封盖,每瓶50毫升;即为一种治疗赤游丹风火热毒证的中药软膏。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910557787.4A CN112089776A (zh) | 2019-06-17 | 2019-06-17 | 一种治疗赤游丹风火热毒证的中药软膏 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910557787.4A CN112089776A (zh) | 2019-06-17 | 2019-06-17 | 一种治疗赤游丹风火热毒证的中药软膏 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112089776A true CN112089776A (zh) | 2020-12-18 |
Family
ID=73748898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910557787.4A Pending CN112089776A (zh) | 2019-06-17 | 2019-06-17 | 一种治疗赤游丹风火热毒证的中药软膏 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112089776A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105663504A (zh) * | 2016-02-14 | 2016-06-15 | 王仲秋 | 一种治疗术口或外伤感染的中药软膏 |
-
2019
- 2019-06-17 CN CN201910557787.4A patent/CN112089776A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105663504A (zh) * | 2016-02-14 | 2016-06-15 | 王仲秋 | 一种治疗术口或外伤感染的中药软膏 |
Non-Patent Citations (3)
Title |
---|
彭佳珍: "《中医护理》", 31 May 1990, 人民卫生出版社 * |
王辉武: "《中医百家药论荟萃》", 28 February 2017, 重庆出版社 * |
陈兰英: "《首都医院制剂汇编》", 31 August 1982, 人民卫生出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103652360A (zh) | 用于治疗猪副伤寒的饲料及其制备方法 | |
CN104337900A (zh) | 槐花植物发酵液及其制备方法 | |
CN103239662A (zh) | 兽用驱虫中药制剂 | |
CN104306679A (zh) | 治疗流行性脑脊髓膜炎的中药剂及其制备方法 | |
CN104001045A (zh) | 一种用于治疗犬肺炎的药物及其制备方法 | |
CN102366520A (zh) | 治疗妇女湿热入侵任脉带下色黄的中草药 | |
CN112089776A (zh) | 一种治疗赤游丹风火热毒证的中药软膏 | |
CN104666799A (zh) | 软组织损伤活血化瘀药酒及制备方法 | |
CN103705614B (zh) | 一种治疗带状疱疹的中药 | |
CN107789607A (zh) | 一种用于治疗寒凝血瘀的中药组合物 | |
CN103860696B (zh) | 一种小儿退黄合剂及制备方法 | |
CN108721534A (zh) | 一种治疗口舌生疮的中药制剂 | |
CN102973711A (zh) | 一种治疗荨麻疹的中药汤剂 | |
CN101496885B (zh) | 一种治疗肿瘤的中草药制剂 | |
CN101085263A (zh) | 治疗尿路感染的中药组合 | |
CN101279040B (zh) | 中药活性防癌疫苗及其制备方法 | |
CN105770844A (zh) | 一种治疗胃及十二指肠溃疡的药物及其制备方法 | |
CN105381064A (zh) | 一种治疗脑出血的中药组合物 | |
CN105125928A (zh) | 一种治疗烫伤的外用膏剂及制备方法 | |
CN117064975A (zh) | 一种治疗儿科腹泻的外用中药按摩膏及其制备方法 | |
CN103623281B (zh) | 一种治疗小儿高热的中药 | |
CN103610995A (zh) | 一种治疗牙龈炎的中药 | |
CN103071000A (zh) | 一种治疗新生儿丹毒的中药组合物 | |
CN110604806A (zh) | 一种治疗小儿咳嗽的中药制剂及其制备方法 | |
CN107854675A (zh) | 一种治疗虚劳病的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201218 |
|
RJ01 | Rejection of invention patent application after publication |